Q06418 (TYRO3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 137.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tyrosine-protein kinase receptor TYRO3 EC=2.7.10.1 Alternative name(s): Tyrosine-protein kinase BYK Tyrosine-protein kinase DTK Tyrosine-protein kinase RSE Tyrosine-protein kinase SKY Tyrosine-protein kinase TIF | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 890 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhances PI3-kinase activity. Activates the AKT survival pathway, including nuclear translocation of NF-kappa-B and up-regulation of transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays a role in various processes such as neuron protection from excitotoxic injury, platelet aggregation and cytoskeleton reorganization. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3. Ref.10 Ref.12 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Monomer and homodimer. Interacts (via N-terminus) with extracellular ligands TULP1 and GAS6 By similarity. Interacts with PIK3R1; this interaction increases PI3-kinase activity By similarity. Ref.8 Ref.13 |
| Subcellular location | |
| Tissue specificity | Abundant in the brain and lower levels in other tissues. |
| Post-translational modification | Autophosphorylated. Ref.7 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. AXL/UFO subfamily. Contains 2 fibronectin type-III domains. Contains 2 Ig-like C2-type (immunoglobulin-like) domains. Contains 1 protein kinase domain. |
| Sequence caution | The sequence BAA21781.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 40 | 40 | Potential | ||||||||||||||||||||||||||||||||||||||||
| Chain | 41 – 890 | 850 | Tyrosine-protein kinase receptor TYRO3 | PRO_0000024478 | |||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 41 – 429 | 389 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 430 – 450 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||
| Topological domain | 451 – 890 | 440 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||
| Domain | 41 – 128 | 88 | Ig-like C2-type 1 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 139 – 220 | 82 | Ig-like C2-type 2 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 225 – 317 | 93 | Fibronectin type-III 1 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 322 – 413 | 92 | Fibronectin type-III 2 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 518 – 790 | 273 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 524 – 532 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||
| Active site | 655 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||
| Binding site | 550 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 681 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 685 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 686 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 804 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 63 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 191 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 230 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 240 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 293 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 366 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 380 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 64 ↔ 117 | Ref.13 | |||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 160 ↔ 203 | Ref.13 | |||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 21 | 1 | P → L. Ref.5 Corresponds to variant rs17854578 [ dbSNP | Ensembl ]. | VAR_045886 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 346 | 1 | I → N. Corresponds to variant rs12148316 [ dbSNP | Ensembl ]. | VAR_045887 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 542 | 1 | G → S. Ref.5 Corresponds to variant rs17857363 [ dbSNP | Ensembl ]. | VAR_045888 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 815 | 1 | A → V. Ref.3 Corresponds to variant rs1042057 [ dbSNP | Ensembl ]. | VAR_045889 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 819 | 1 | L → M. Ref.5 Corresponds to variant rs17854579 [ dbSNP | Ensembl ]. | VAR_045890 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 824 | 1 | R → G. Ref.5 Corresponds to variant rs17857364 [ dbSNP | Ensembl ]. | VAR_045891 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 831 | 1 | A → T. Ref.14 | VAR_041876 | |||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 99 | 1 | I → R: Abolishes dimerization. Ref.13 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 29 – 36 | 8 | Missing in AAC50070. Ref.3 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 285 | 1 | L → F in BAA21781. Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 293 | 1 | N → I in BAA21781. Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 341 | 1 | E → V in BAA21781. Ref.4 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 812 | 1 | E → D in BAA21781. Ref.4 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 50 – 55 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 60 – 68 | 9 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 74 – 78 | 5 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 85 – 94 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 97 – 106 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 109 – 111 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 113 – 121 | 9 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 131 – 136 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 140 – 143 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 148 – 150 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 156 – 163 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 165 – 167 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 175 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 183 – 192 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 199 – 207 | 9 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 210 – 213 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 217 – 221 | 5 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "RSE, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain." Mark M.R., Scadden D.T., Wang Z., Gu Q., Goddard A., Godowski P.J. J. Biol. Chem. 269:10720-10728(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Cloning of the cDNA for a novel receptor tyrosine kinase, Sky, predominantly expressed in brain." Ohashi K., Mizuno K., Kuma K., Miyata T., Nakamura T. Oncogene 9:699-705(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Isolation and characterization of the human DTK receptor tyrosine kinase." Crosier K.E., Hall L.R., Lewis P.M., Morris C.M., Wood C.R., Morris J.C., Crosier P.S. Growth Factors 11:137-144(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT VAL-815. Tissue: Brain. |
| [4] | "A tyrosine kinase-like molecule is localized in the nuclear membrane of neurons: hippocampal behavior under stress." Kajii Y., Ninomiya D., Kato M., Mizuguchi M., Saji M., Katsumoto T., Ohno K., Takashima S., Onodera K. Biol. Cell 88:45-54(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS LEU-21; SER-542; MET-819 AND GLY-824. Tissue: Skin and Testis. |
| [6] | "The human TYRO3 gene and pseudogene are located in chromosome 15q14-q25." Polvi A., Armstrong E., Lai C., Lemke G., Huebner K., Spritz R.A., Giuda L.C., Nicholls R.D., Alitalo K. Gene 134:289-293(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 519-720. |
| [7] | "Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase." Toshima J., Ohashi K., Iwashita S., Mizuno K. Biochem. Biophys. Res. Commun. 209:656-663(1995) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOPHOSPHORYLATION. |
| [8] | "Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3." Godowski P.J., Mark M.R., Chen J., Sadick M.D., Raab H., Hammonds R.G. Cell 82:355-358(1995) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GAS6. |
| [9] | "Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases." Hafizi S., Dahlback B. Cytokine Growth Factor Rev. 17:295-304(2006) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION. |
| [10] | "Tyro3 family-mediated cell entry of Ebola and Marburg viruses." Shimojima M., Takada A., Ebihara H., Neumann G., Fujioka K., Irimura T., Jones S., Feldmann H., Kawaoka Y. J. Virol. 80:10109-10116(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION AS CELL ENTRY FACTOR IN FILOVIRUS INFECTION. |
| [11] | "Immunobiology of the TAM receptors." Lemke G., Rothlin C.V. Nat. Rev. Immunol. 8:327-336(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION. |
| [12] | "Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization." Cosemans J.M., Van Kruchten R., Olieslagers S., Schurgers L.J., Verheyen F.K., Munnix I.C., Waltenberger J., Angelillo-Scherrer A., Hoylaerts M.F., Carmeliet P., Heemskerk J.W. J. Thromb. Haemost. 8:1797-1808(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PLATELET ACTIVATION. |
| [13] | "Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family." Heiring C., Dahlbaeck B., Muller Y.A. J. Biol. Chem. 279:6952-6958(2004) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 41-222, SUBUNIT, INTERACTION WITH GAS6, MUTAGENESIS OF ILE-99, DISULFIDE BONDS. |
| [14] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] THR-831. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U05682 mRNA. Translation: AAA19236.1. D17517 mRNA. Translation: BAA04467.1. U18934 mRNA. Translation: AAC50070.1. D50479 mRNA. Translation: BAA21781.1. Different initiation. BC049368 mRNA. Translation: AAH49368.1. BC051756 mRNA. Translation: AAH51756.1. X72886 mRNA. Translation: CAA51396.1. | ||||||||||||
| IPI | IPI00030887. | ||||||||||||
| PIR | A53743. I38912. | ||||||||||||
| RefSeq | NP_006284.2. NM_006293.3. | ||||||||||||
| UniGene | Hs.381282. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q06418. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q06418. 2 interactions. | ||||||||||||
| STRING | 9606.ENSP00000263798. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q06418. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 1717829. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q06418. | ||||||||||||
| PRIDE | Q06418. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000263798; ENSP00000263798; ENSG00000092445. | ||||||||||||
| GeneID | 7301. | ||||||||||||
| KEGG | hsa:7301. | ||||||||||||
| UCSC | uc001zof.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 7301. | ||||||||||||
| GeneCards | GC15P041851. | ||||||||||||
| HGNC | HGNC:12446. TYRO3. | ||||||||||||
| MIM | 600341. gene. | ||||||||||||
| neXtProt | NX_Q06418. | ||||||||||||
| PharmGKB | PA37097. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOVERGEN | HBG006346. | ||||||||||||
| InParanoid | Q06418. | ||||||||||||
| KO | K05116. | ||||||||||||
| OMA | HAGQQGP. | ||||||||||||
| OrthoDB | EOG4H4639. | ||||||||||||
| PhylomeDB | Q06418. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.10.1. 2681. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q06418. | ||||||||||||
| Bgee | Q06418. | ||||||||||||
| CleanEx | HS_TYRO3. | ||||||||||||
| Genevestigator | Q06418. | ||||||||||||
| GermOnline | ENSG00000092445. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 4 hits. | ||||||||||||
| InterPro | IPR003961. Fibronectin_type3. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR013098. Ig_I-set. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. [Graphical view] | ||||||||||||
| Pfam | PF00041. fn3. 2 hits. PF07679. I-set. 1 hit. PF07714. Pkinase_Tyr. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||
| SMART | SM00060. FN3. 2 hits. SM00409. IG. 1 hit. SM00408. IGc2. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. SSF56112. Kinase_like. 1 hit. | ||||||||||||
| PROSITE | PS50853. FN3. 2 hits. PS50835. IG_LIKE. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q06418. | ||||||||||||
| ChEMBL | CHEMBL5314. | ||||||||||||
| EvolutionaryTrace | Q06418. | ||||||||||||
| GenomeRNAi | 7301. | ||||||||||||
| NextBio | 28553. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | TYRO3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q06418 Secondary accession number(s): O14953, Q86VR3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 15 Human chromosome 15: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
